VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,958,000 | +35.3% | 94,300 | -6.7% | 0.06% | +12.0% |
| Q3 2017 | $1,447,000 | +16.7% | 101,100 | +40.8% | 0.05% | +47.1% |
| Q2 2017 | $1,240,000 | +350.9% | 71,800 | +187.2% | 0.03% | +385.7% |
| Q1 2017 | $275,000 | -85.7% | 25,000 | -81.1% | 0.01% | -88.1% |
| Q4 2016 | $1,923,000 | +141.3% | 132,500 | +307.7% | 0.06% | +247.1% |
| Q3 2016 | $797,000 | -60.2% | 32,500 | -67.4% | 0.02% | -55.3% |
| Q2 2016 | $2,005,000 | -40.2% | 99,600 | -21.9% | 0.04% | -62.7% |
| Q1 2016 | $3,355,000 | +87.5% | 127,600 | +625.0% | 0.10% | +112.5% |
| Q4 2015 | $1,789,000 | -18.0% | 17,600 | +1.7% | 0.05% | +71.4% |
| Q2 2014 | $2,181,000 | -74.7% | 17,300 | -73.5% | 0.03% | -74.5% |
| Q1 2014 | $8,607,000 | – | 65,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |